Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Aodong Pharmaceutical Group Yanji is a core subsidiary of the Jilin Aodong Pharmaceutical Group, a leading pharmaceutical company in China. Headquartered in Yanji, Jilin Province, the company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicines (TCM) and modern chemical drugs. Its product portfolio is diverse, featuring flagship treatments for neurasthenia, cardiovascular conditions, and gastrointestinal ailments. The company is particularly well-known for its Anshen Bunao Liquid, which has maintained a significant market share in the neurological health segment for decades. Operating under stringent GMP standards, the Yanji facility serves as a critical production hub for the group's domestic and international supply chains. The company continues to modernize traditional formulas through advanced extraction and preparation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Aodong Pharmaceutical Industry Group Yanji.